LCWP
BSX icon

Legacy Capital Wealth Partners’s Boston Scientific BSX Stock Holding History

Legacy Capital Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
7,913
+2,266
+40% +$123K 0.06% 275
2026
Q1 		$354K Buy
5,647
+834
+17% +$66.7K 0.07% 271
2025
Q4 		$459K Buy
4,813
+630
+15% +$61.8K 0.1% 217
2025
Q3 		$408K Buy
4,183
+458
+12% +$47.4K 0.09% 245
2025
Q2 		$400K Buy
3,725
+351
+10% +$35.5K 0.09% 248
2025
Q1 		$340K Buy
3,374
+267
+9% +$26.9K 0.08% 260
2024
Q4 		$278K Buy
+3,107
New +$274K 0.07% 284

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Legacy Capital Wealth Partners's BSX Position: Q2 2026 in Review

Legacy Capital Wealth Partners increased its Boston Scientific (BSX) stake by 40% in Q2 2026, buying an estimated $123K and bringing the position to 7,913 shares worth $338K. The position accounts for 0.06% of the portfolio, ranked #275.

Legacy Capital Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $459K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Legacy Capital Wealth Partners held 7,913 shares of Boston Scientific worth $338K as of Q2 2026.
  • Legacy Capital Wealth Partners bought 2,266 Boston Scientific shares in Q2 2026, an estimated $123K.
  • Boston Scientific made up 0.06% of Legacy Capital Wealth Partners's portfolio in Q2 2026, its #275 holding.
  • Legacy Capital Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Legacy Capital Wealth Partners's Boston Scientific position peaked at $459K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.